Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03762213 · ClinicalTrials.gov registry record · NA
Audio-Visual Relaxation Technology for Pediatric Amplified Musculoskeletal Pain Syndrome
A NA study, sponsored by Tufts Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03762213 is a NA study that has completed, run by Tufts Medical Center. The registered enrollment target is 30 participants.
The verdict
NCT03762213, a NA study, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
A pilot randomized controlled trial to assess feasibility, acceptability and generate outcome domains for a future RCT testing the efficacy of immersive virtual reality on pain intensity in pediatric amplified musculoskeletal pain syndrome.
Interventions
- DEVICE Oculus GO VR HMD, application Happy Place (© Mimerse)
- DEVICE iPad, application Happy Place (© Mimerse)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-12-20 |
| Est. Completion | 2019-08-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03762213
The ClinicalTrials.gov registry entry for NCT03762213 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oculus GO VR HMD, application Happy Place (© Mimerse) is the first listed.
NCT03762213 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03762213 about?
NCT03762213 is a clinical study titled "Audio-Visual Relaxation Technology for Pediatric Amplified Musculoskeletal Pain Syndrome". A pilot randomized controlled trial to assess feasibility, acceptability and generate outcome domains for a future RCT testing the efficacy of immersive virtual reality on pain intensity in pediatric amplified musculoskeletal pain syndrome.
What is the current status of trial NCT03762213?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-12-20. Estimated completion is 2019-08-29.
What interventions are being tested in trial NCT03762213?
The interventions under investigation include: Oculus GO VR HMD, application Happy Place (© Mimerse) (DEVICE), iPad, application Happy Place (© Mimerse) (DEVICE).
Who is sponsoring clinical trial NCT03762213?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.